Back to
Wasatch Advisors LP
VKTX
15 quarters
Position history for
Wasatch Advisors LP's holdings in Viking Therapeutics, Inc.
Yes. Wasatch Advisors holds 198,136 shares of VKTX (Viking Therapeutics), worth $6.5M, as of its Q3 2026 13F filing. It reduced the position by 114,631 shares (-36.7%) from Q2 2026. Wasatch Advisors has held VKTX since Q1 2023, across 15 quarterly 13F filings.
Current Value
$6.5M
Current Shares
198,136
Total Value Change
-$21.9M
Total Shares Change
-1.5M
Quarter-by-Quarter History
Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.